Understanding PANoptosis in Diabetic Retinopathy: Immunological Mechanisms and Potential Therapeutic Approaches
-
By
-
Lingli Ma
-
Ning Hou
-
Xiaoyu Zhao
-
Zimeng Li
-
Qing Liu
-
Jianyu Zhao
-
Qing Wang
-
June 19, 2026
Clinical Scorecard: Understanding PANoptosis in Diabetic Retinopathy: Immunological Mechanisms and Potential Therapeutic Approaches
At a Glance
| Category | Detail |
|---|
| Condition | Diabetic Retinopathy |
| Key Mechanisms | PANoptosis, oxidative stress, inflammation, programmed cell death |
| Target Population | Diabetic patients, particularly those with retinal complications |
| Care Setting | Ophthalmology and diabetes management clinics |
Key Highlights
- PANoptosis integrates apoptosis, pyroptosis, and necroptosis in DR progression.
- Hyperglycemia-induced oxidative stress is a key driver of retinal neurodegeneration.
- Emerging biomarkers related to PANoptosis may aid in diagnosis and treatment.
- Therapeutic strategies should focus on localized, biomarker-guided interventions.
- Challenges include blood-retinal barrier penetration and systemic immune side effects.
Guideline-Based Recommendations
Diagnosis
- Utilize PANoptosis-related gene signatures as potential biomarkers.
Management
- Prioritize localized delivery of PANoptosis inhibitors and other therapeutic agents.
Monitoring & Follow-up
- Conduct longitudinal biomarker cohort studies to track disease progression.
Risks
- Consider potential safety risks of non-selective PANoptosis blockade.
Patient & Prescribing Data
Patients with diabetic retinopathy and associated complications.
Focus on small-molecule inhibitors and gene interventions targeting PANoptosis.
Clinical Best Practices
- Implement cell-type-specific modulation of PANoptosis pathways.
- Adopt a time-dependent approach to intervention based on disease stage.
Related Resources & Content
